Studying rare adverse events is crucial for several reasons:
1. Patient Safety: Ensuring that medical treatments do more good than harm. 2. Regulation Compliance: Regulatory agencies like the FDA require monitoring and reporting of adverse events. 3. Improving Medical Guidelines: Clinical guidelines can be updated based on new evidence from rare adverse event studies.
